{
  "DOI": "10.1186/s40246-022-00446-4",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00446-4",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eBlood plasma, one of the most studied liquid biopsies, contains various molecules that have biomarker potential for cancer detection, including cell-free DNA (cfDNA) and cell-free RNA (cfRNA). As the vast majority of cell-free nucleic acids in circulation are non-cancerous, a laboratory workflow with a high detection sensitivity of tumor-derived nucleic acids is a prerequisite for precision oncology. One way to meet this requirement is by the combined analysis of cfDNA and cfRNA from the same liquid biopsy sample. So far, no study has systematically compared the performance of cfDNA and cfRNA co-purification to increase sensitivity.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eFirst, we set up a framework using digital PCR (dPCR) technology to quantify cfDNA and cfRNA from human blood plasma in order to compare cfDNA/cfRNA co-purification kit performance. To that end, we optimized two dPCR duplex assays, designed to quantify both cfDNA and cfRNA with the same assays, by ensuring that primers and probes are located within a highly abundant exon. Next, we applied our optimized workflow to evaluate the co-purification performance of two manual and two semi-automated methods over a range of plasma input volumes (0.06–4 mL). Some kits result in higher nucleic acid concentrations in the eluate, while consuming only half of the plasma volume. The combined nucleic acid quantification systematically results in higher nucleic acid concentrations as compared to a parallel quantification of cfDNA and cfRNA in the eluate.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe provide a framework to evaluate the performance of cfDNA/cfRNA co-purification kits and have tested two manual and two semi-automated co-purification kits in function of the available plasma input amount and the intended use of the nucleic acid eluate. We demonstrate that the combined quantification of cfDNA and cfRNA has a benefit compared to separate quantification. We foresee that the results of this study are instrumental for clinical applications to help increase mutation detection sensitivity, allowing improved disease detection and monitoring.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "446"
  ],
  "article-number": "73",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "6 October 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "19 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "31 December 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Sample collection was approved by the ethics committee of Ghent University Hospital (registration number B670201733701) and written informed consent was obtained from the healthy donors."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors approve the publication of this manuscript."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Deleu",
      "given": "Jill",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Schoofs",
      "given": "Kathleen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Decock",
      "given": "Anneleen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Verniers",
      "given": "Kimberly",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roelandt",
      "given": "Sofie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Denolf",
      "given": "Angie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Verreth",
      "given": "Joke",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "De Wilde",
      "given": "Bram",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Van Maerken",
      "given": "Tom",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "De Preter",
      "given": "Katleen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vandesompele",
      "given": "Jo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        12,
        31
      ]
    ],
    "date-time": "2022-12-31T13:02:45Z",
    "timestamp": 1672491765000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        1,
        3
      ]
    ],
    "date-time": "2023-01-03T17:10:11Z",
    "timestamp": 1672765811000
  },
  "funder": [
    {
      "DOI": "10.13039/501100003130",
      "award": [
        "LIQUIDHOPE TRANSCAN-2 project",
        "LIQUIDHOPE TRANSCAN-2 project",
        "senior clinical researcher grant",
        "LIQUIDHOPE TRANSCAN-2 project"
      ],
      "doi-asserted-by": "publisher",
      "name": "Fonds Wetenschappelijk Onderzoek"
    },
    {
      "DOI": "10.13039/501100011851",
      "award": [
        "2022/13037"
      ],
      "doi-asserted-by": "publisher",
      "name": "Kom op tegen Kanker"
    },
    {
      "DOI": "10.13039/501100007229",
      "award": [
        "BOF22/CDV/077",
        "GOA Gent-Lung",
        "BOF22/CDV/077",
        "BOF22/CDV/077",
        "GOA Gent-Lung",
        "BOF22/CDV/077"
      ],
      "doi-asserted-by": "publisher",
      "name": "Bijzonder Onderzoeksfonds UGent"
    },
    {
      "DOI": "10.13039/501100005026",
      "award": [
        "2018-092",
        "2018-092"
      ],
      "doi-asserted-by": "publisher",
      "name": "Stichting Tegen Kanker"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        1,
        4
      ]
    ],
    "date-time": "2023-01-04T07:01:08Z",
    "timestamp": 1672815668745
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        12,
        31
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            12,
            31
          ]
        ],
        "date-time": "2022-12-31T00:00:00Z",
        "timestamp": 1672444800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            12,
            31
          ]
        ],
        "date-time": "2022-12-31T00:00:00Z",
        "timestamp": 1672444800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00446-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00446-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00446-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        12,
        31
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        12,
        31
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3390/ijms222010931",
      "author": "SN Aleksakhina",
      "doi-asserted-by": "publisher",
      "first-page": "10931",
      "journal-title": "Int J Mol Sci",
      "key": "446_CR1",
      "unstructured": "Aleksakhina SN, Imyanitov EN. Cancer therapy guided by mutation tests: current status and perspectives. Int J Mol Sci. 2021;22:10931.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.3390/genes12030349",
      "author": "I Martins",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Genes",
      "key": "446_CR2",
      "unstructured": "Martins I, Ribeiro IP, Jorge J, Gonçalves AC, Sarmento-Ribeiro AB, Melo JB, et al. Liquid biopsies: applications for cancer diagnosis and monitoring. Genes. 2021;12:1–20.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s40883-019-00141-2",
      "author": "S Bratulic",
      "doi-asserted-by": "publisher",
      "first-page": "312",
      "issue": "3",
      "journal-title": "Regen Eng Transl Med",
      "key": "446_CR3",
      "unstructured": "Bratulic S, Gatto F, Nielsen J. The translational status of cancer liquid biopsies. Regen Eng Transl Med. 2021;7(3):312–52.",
      "volume": "7",
      "year": "2021"
    },
    {
      "DOI": "10.3390/ijms19102877",
      "author": "J Marrugo-Ramírez",
      "doi-asserted-by": "publisher",
      "first-page": "2877",
      "journal-title": "Int J Mol Sci",
      "key": "446_CR4",
      "unstructured": "Marrugo-Ramírez J, Mir M, Samitier J. Blood-based cancer biomarkers in liquid biopsy: a promising non-invasive alternative to tissue biopsy. Int J Mol Sci. 2018;19:2877.",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s12943-022-01543-7",
      "author": "SN Lone",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Mol Cancer",
      "key": "446_CR5",
      "unstructured": "Lone SN, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022;21:1–22.",
      "volume": "21",
      "year": "2022"
    },
    {
      "DOI": "10.1007/s00431-019-03545-y",
      "author": "R van Paemel",
      "doi-asserted-by": "publisher",
      "first-page": "191",
      "journal-title": "Eur J Pediatr",
      "key": "446_CR6",
      "unstructured": "van Paemel R, Vlug R, de Preter K, van Roy N, Speleman F, Willems L, et al. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review. Eur J Pediatr. 2020;179:191–202.",
      "volume": "179",
      "year": "2020"
    },
    {
      "DOI": "10.2144/btn-2020-0124",
      "author": "MS Frank",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "issue": "4",
      "journal-title": "Biotechniques",
      "key": "446_CR7",
      "unstructured": "Frank MS, Fuß J, Steiert TA, Streleckiene G, Gehl J, Forster M. Quantifying sequencing error and effective sequencing depth of liquid biopsy NGS with UMI error correction. Biotechniques. 2021;70(4):227–32.",
      "volume": "70",
      "year": "2021"
    },
    {
      "DOI": "10.1093/annonc/mdx765",
      "author": "AK Krug",
      "doi-asserted-by": "publisher",
      "first-page": "700",
      "issue": "3",
      "journal-title": "Ann Oncol",
      "key": "446_CR8",
      "unstructured": "Krug AK, Enderle D, Karlovich C, Priewasser T, Bentink S, Spiel A, et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Ann Oncol. 2018;29(3):700–6.",
      "volume": "29",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41467-021-22444-1",
      "author": "MH Larson",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "446_CR9",
      "unstructured": "Larson MH, Pan W, Kim HJ, Mauntz RE, Stuart SM, Pimentel M, et al. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun. 2021;12(1):1–11.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-3369",
      "author": "E Castellanos-Rizaldos",
      "doi-asserted-by": "publisher",
      "first-page": "2944",
      "issue": "12",
      "journal-title": "Clin Cancer Res",
      "key": "446_CR10",
      "unstructured": "Castellanos-Rizaldos E, Grimm DG, Tadigotla V, Hurley J, Healy J, Neal PL, et al. Exosome-based detection of EGFR T790M in plasma from non-small cell lung cancer patients. Clin Cancer Res. 2018;24(12):2944–50.",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-2007",
      "author": "L Möhrmann",
      "doi-asserted-by": "publisher",
      "first-page": "181",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "446_CR11",
      "unstructured": "Möhrmann L, Huang HJ, Hong DS, Tsimberidou AM, Fu S, Piha-Paul SA, et al. Liquid biopsies using plasma exosomal nucleic acids and plasma cell-free DNA compared with clinical outcomes of patients with advanced cancers. Clin Cancer Res. 2018;24(1):181–8.",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.3402/jev.v3.24858",
      "author": "J van Deun",
      "doi-asserted-by": "publisher",
      "first-page": "24858",
      "issue": "1",
      "journal-title": "J Extracell Vesicles",
      "key": "446_CR12",
      "unstructured": "van Deun J, Mestdagh P, Sormunen R, Cocquyt V, Vermaelen K, Vandesompele J, et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles. 2014;3(1):24858.",
      "volume": "3",
      "year": "2014"
    },
    {
      "DOI": "10.1080/2162402X.2017.1376153",
      "author": "L König",
      "doi-asserted-by": "publisher",
      "first-page": "e1376153",
      "issue": "1",
      "journal-title": "Oncoimmunology.",
      "key": "446_CR13",
      "unstructured": "König L, Kasimir-Bauer S, Bittner AK, Hoffmann O, Wagner B, Santos Manvailer LF, et al. Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy. Oncoimmunology. 2018;7(1):e1376153.",
      "volume": "7",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s00216-020-02490-2",
      "author": "M Sidstedt",
      "doi-asserted-by": "publisher",
      "first-page": "2009",
      "journal-title": "Anal Bioanal Chem",
      "key": "446_CR14",
      "unstructured": "Sidstedt M, Rådström P, Hedman J. PCR inhibition in qPCR, dPCR and MPS—mechanisms and solutions. Anal Bioanal Chem. 2020;412:2009–23.",
      "volume": "412",
      "year": "2020"
    },
    {
      "key": "446_CR15",
      "unstructured": "Anckaert J, Avila Cobos F, Decock A, Deleu J, de Wever O, de Wilde J, et al. Performance of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study. bioRxiv [Internet]. 2021;2021.05.11.442610. Available from: http://biorxiv.org/content/early/2021/05/11/2021.05.11.442610.abstract"
    },
    {
      "DOI": "10.1093/nar/gkw010",
      "author": "N Hug",
      "doi-asserted-by": "publisher",
      "first-page": "1483",
      "journal-title": "Nucl Acids Res",
      "key": "446_CR16",
      "unstructured": "Hug N, Longman D, Cáceres JF. Mechanism and regulation of the nonsense-mediated decay pathway. Nucl Acids Res. 2015;44:1483–95.",
      "volume": "44",
      "year": "2015"
    },
    {
      "key": "446_CR17",
      "unstructured": "Primer3Plus tool. https://www.primer3plus.com. Accessed 7 October 2020."
    },
    {
      "key": "446_CR18",
      "unstructured": "BiSearch Primer Design and Search Tool. http://bisearch.enzim.hu. Accessed 7 October 2020."
    },
    {
      "key": "446_CR19",
      "unstructured": "UCSC In-Silico PCR. https://genome.ucsc.edu/cgi-bin/hgPcr. Accessed 7 October 2020."
    },
    {
      "key": "446_CR20",
      "unstructured": "OligoEvaluator tool. http://www.oligoevaluator.com/OligoCalcServlet. Accessed 7 October 2020."
    },
    {
      "key": "446_CR21",
      "unstructured": "SBT tool. https://masckareem.shinyapps.io/sbtmodel/. Accessed 7 October 2020."
    },
    {
      "DOI": "10.1087/20150211",
      "author": "A Brand",
      "doi-asserted-by": "publisher",
      "first-page": "151",
      "issue": "2",
      "journal-title": "Learned Publishing",
      "key": "446_CR22",
      "unstructured": "Brand A, Allen L, Altman M, Hlava M, Scott J. Beyond authorship: attribution, contribution, collaboration, and credit. Learned Publishing. 2015;28(2):151–5.",
      "volume": "28",
      "year": "2015"
    }
  ],
  "reference-count": 22,
  "references-count": 22,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00446-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}